Drugs for Inflammatory Bowel Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 345)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Zinc cation |
Approved, Experimental, Investigational |
Phase 4 |
|
7440-66-6, 23713-49-7 |
32051 |
Synonyms:
alpha D Mannosidase
alpha D Mannoside mannohydrolase
alpha Mannosidase
alpha Mannosidase b
alpha-D-Mannosidase
alpha-D-Mannoside mannohydrolase
alpha-Mannosidase
alpha-Mannosidase, lysosomal
alpha-Mannosidase, neutral
Dietary zinc
LAMAN
Lysosomal alpha mannosidase
Lysosomal alpha-mannosidase
Mannohydrolase, alpha-D-mannoside
Mannosidase b, alpha
Neutral alpha mannosidase
|
Neutral alpha-mannosidase
Topostin b
Zinc cation
ZINC ion
Zinc ion(2+)
Zinc(2+)
Zinc(II)
Zinc, chelated
Zinc, elemental
Zinc, ion (ZN2+)
zinc|zinc ion
Zincum metallicum
Zn
ZN(2+)
ZN(II)
ZN2+
|
|
2 |
|
Copper |
Approved, Investigational |
Phase 4 |
|
7440-50-8 |
27099 |
Synonyms:
cobre
COPPER (II) ion
Copper(II) cation
Copper, ion (cu2+)
Cu
Cu(2+)
|
Cu(II)
Cu2+
cuivre
Cupric ion
cuprum
Kupfer
|
|
3 |
|
Ustekinumab |
Approved, Investigational |
Phase 4 |
|
815610-63-0 |
|
Synonyms:
CNTO-1275
STELARA
STELERA
|
|
|
4 |
|
Prucalopride |
Approved |
Phase 4 |
|
179474-81-8 |
3052762 |
Synonyms:
4-Amino-5-chloro-N-(1-(3-methoxypropyl)-4-piperidinyl)-2,3-dihydro-1-benzofuran-7-carboxamide
4-Amino-5-chloro-N-[1-(3-methoxypropyl)piperidin-4-yl]-2,3-dihydro-1-benzofuran-7-carboximidate
Motegrity®|R-093877|R-108512|Resolor®
Prucaloprida
PRUCALOPRIDE
R-093877
|
R-093877Prucalopride
R-108512
Resolor
Resotran
Resotrans
|
|
5 |
|
Fentanyl |
Approved, Illicit, Investigational, Vet_approved |
Phase 4 |
|
437-38-7 |
3345 |
Synonyms:
1-Phenethyl-4-(N-phenylpropionamido)piperidine
1-Phenethyl-4-N-propionylanilinopiperidine
ABSTRAL
Abstral®|Actiq®|Durogesic®|Effentora®|MCN-JR-4263-49|R-4263|Sublimaze®
ACTIQ
AD 923
AD-923
BREAKYL
Cephalon brand OF fentanyl buccal oravescent
Duragesic
DURAGESIC-100
DURAGESIC-12
DURAGESIC-25
DURAGESIC-37
DURAGESIC-50
DURAGESIC-75
Durogesic
DUROGESIC DTRANS
EFFENTORA
FENCINO
FENTALIS RESERVOIR
Fentanest
Fentanil
Fentanila
Fentanila [INN-Spanish]
Fentanilo
Fentanyl
Fentanyl CII
Fentanyl citrate
FENTANYL-100
FENTANYL-12
FENTANYL-25
FENTANYL-37
FENTANYL-50
FENTANYL-62
FENTANYL-75
FENTANYL-87
Fentanylum
|
Fentanylum [INN-Latin]
Fentora
IDS-NF-001
INNOVAR
IONSYS
Janssen pharmaceutica brand OF fentanyl
LEPTANAL
MATRIFEN
MCN-JR-4263-49
MEZOLAR MATRIX
MYLAFENT
N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-Phenethyl-4-piperidyl)propionanilide
N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide
N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide
N02AB03
Nasalfent
N-Phenethyl-4-(N-propionylanilino)piperidine
N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
OPIODUR
ORALET
OSMACH
OSMANIL
PECFENT
Pentanyl
Phentanyl
R 4263
R-4263
Rapinyl
RECIVIT
Sentonil
Sublimaze
Subsys
TILOFYL
Transmucosal oral fentanyl citrate
VICTANYL
YEMEX
|
|
6 |
|
Midazolam |
Approved, Illicit |
Phase 4 |
|
59467-70-8 |
4192 |
Synonyms:
Buccolam
Buccolam®|Dormicum®|Nayzilam®|USL261 (nasal spray formulation)|Versed®
Dea no. 2884
Dormicum
Hydrochloride, midazolam
Maleate, midazolam
Mezolam
Midazolam
Midazolam base
MIDAZOLAM CIV
|
Midazolam Hcl
Midazolam hydrochloride
Midazolam maleate
Midazolamum
Midazolamum [INN-Latin]
Nayzilam
USL261
USL-261
Versed
|
|
7 |
|
Propofol |
Approved, Investigational, Vet_approved |
Phase 4 |
|
2078-54-8 |
4943 |
Synonyms:
2,6 Diisopropylphenol
2,6-Bis(1-methylethyl)phenol
2,6-Diisopropylphenol
2,6-diisopropylphenol|Diprivan®|ICI 35868
Abbott brand OF propofol
Alpha Brand OF propofol
Aquafol
Astra brand OF propofol
AstraZeneca brand OF propofol
Braun brand OF propofol
Curamed brand OF propofol
Diisopropylphenol
Diprivan
Disoprivan
Disoprofol
Fresenius brand OF propofol
Fresenius kabi brand OF propofol
Fresofol
ICI 35868
ICI 35-868
|
ICI35,868
ICI-35868
Ivofol
Juste brand OF propofol
NSC-5105
Parnell brand OF propofol
Pisa brand OF propofol
Propofol
Propofol abbott
Propofol fresenius
Propofol MCT
Propofol rovi
Propofol-lipuro
Propofolum
Rapinovet
Recofol
Rovi brand OF propofol
Schering brand OF propofol
Zeneca brand OF propofol
|
|
8 |
|
Lubiprostone |
Approved, Investigational |
Phase 4 |
|
136790-76-6 |
656719 157920 |
Synonyms:
0211, SPI
7-[(2R,4AR,5S,7ar)-2-(1,1-difluoropentyl)-2-hydroxy-6-oxo-octahydrocyclopenta[b]pyran-5-yl]heptanoate
Amitiza
Amitiza®|SPI-0211
|
Lubiprostone
RU-0211
SPI-0211
|
|
9 |
|
Fidaxomicin |
Approved |
Phase 4 |
|
873857-62-6 |
151383 |
Synonyms:
6-{[12-({3,4-dihydroxy-6,6-dimethyl-5-[(2-methylpropanoyl)oxy]oxan-2-yl}oxy)-11-ethyl-8-hydroxy-18-(1-hydroxyethyl)-9,13,15-trimethyl-2-oxo-1-oxacyclooctadeca-3,5,9,13,15-pentaen-3-yl]methoxy}-4-hydroxy-5-methoxy-2-methyloxan-3-yl 3,5-dichloro-2-ethyl-4,6-dihydroxybenzoic acid
Dificid
Difimicin
Fidaxomicin
Fidaxomicina
Lipiarmicin
Lipiarmycin
Lipiarmycin a3
Lipiarmycin a4
|
Lipiarmycin b
Lipiarmycin b3
Lipiarmycin b4
Lipiarrmycin
PAR 101
PAR-101
Tiacumicin b
Tiacumicin C
|
|
10 |
|
Rosiglitazone |
Approved, Investigational |
Phase 4 |
|
122320-73-4, 155141-29-0 |
77999 |
Synonyms:
(±)-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione
(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion
5-((4-(2-(Methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione
5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate
AVANDAMET
AVANDARYL
Avandia
Avandia®|rosiglizole
BRL-49653
BRL-49653C
BRL-49653-C
Gaudil
|
Glaxo wellcome brand OF rosiglitazone maleate
GlaxoSmithKline brand OF rosiglitazone maleate
Rosigliazone maleate
Rosiglitazon
Rosiglitazona
Rosiglitazone
Rosiglitazone maleate
Rosiglitazonum
Rosiglizole
SmithKline beecham brand OF rosiglitazone maleate
TDZ-01
|
|
11 |
|
Dexamethasone acetate |
Approved, Investigational, Vet_approved |
Phase 4 |
|
1177-87-3 |
3680 |
Synonyms:
16alpha-Methyl-9alpha-fluoroprednisolone 21-acetate
2-{1-fluoro-14,17-dihydroxy-2,13,15-trimethyl-5-oxotetracyclo[8.7.0.0,.0,]heptadeca-3,6-dien-14-yl}-2-oxoethyl acetic acid
9alpha-Fluoro-16alpha-methylprednisolone acetate
DECADRON-LA
Dexamethasone 21-acetate
|
DEXAMETHASONE ACETATE
Dexamethasone acetate anhydrous
Dexamethasone acetate, anhydrous
Dexamethasone acetic acid
Dexamethasoni acetas
|
|
12 |
|
Dexamethasone |
Approved, Investigational, Vet_approved |
Phase 4 |
|
50-02-2 |
3003 5743 |
Synonyms:
[<sup>3</sup>H]-dexamethasone
16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol
16alpha -Methyl-9alpha -fluoroprednisolone
16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol
16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol
16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone
16alpha-Methyl-9alpha-fluoroprednisolone
16-alpha-Methyl-9-alpha-fluoroprednisolone
16a-Methyl-9a-fluoro-1-dehydrocortisol
16Α-methyl-9α-fluoro-1-dehydrocortisol
1-Dehydro-16alpha -methyl-9alpha -fluorohydrocortisone
1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone
1-Dehydro-16a-methyl-9a-fluorohydrocortisone
1-Dehydro-16α-methyl-9α-fluorohydrocortisone
9a-Fluoro-16a-methylprednisolone
9a-Fluoro-16BETA-methylprednisolone
9alpha -Fluoro-16alpha -methylprednisolone
9alpha-Fluoro-16alpha-methylprednisolone
9alpha-Fluoro-16alpha-methyl-prednisolone
9-alpha-Fluoro-16-alpha-methylprednisolone
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11alpha -methylpregna-1,4-diene-3,20-dione
9-Fluoro-16-methylprednisolone
9Α-fluoro-16α-methylprednisolone
Adexone
Aeroseb-D
Aeroseb-dex
Ak dex OPH otic soln 0.1%
Alcon brand OF dexamethasone
alpha -Fluoro-16-alpha -methylcortisol
Anaflogistico
Aphtasolon
Aphthasolone
Apo-dexamethasone
Auxiron
Azimycin (veterinary)
Azium
Azium (veterinary)
Bisu DS
Calonat
Corson
Corsone
Cortisumman
DALALONE
Decacort
Decacortin
Decaderm
Decadron
Decadron Tablets, Elixir
Decadron®|desametasone|fluormethylprednisolone
DECADRON-75
DECADRON-LA
Decagel
Decaject
Decaject l.a.
Decaject-l.a.
Decalix
Decameth
Decasone
Decaspray
Dectancyl
Dekacort
Delta1-9alpha-Fluoro-16alpha-methylcortisol
Deltafluorene
Dergramin
Deronil
Desadrene
Desametasone
Desametasone [Dcit]
Desamethasone
Desameton
Deseronil
DEX
DEXA
Dexa mamallet
DEXACEN-4
Dexacidin
Dexacort
Dexacortal
Dexa-cortidelt
Dexacortin
Dexa-cortisyl
DEXACORTISYL
Dexadeltone
Dexafarma
DEXAFREE
DEXAIR
Dexalona
Dexaltin
Dexa-Mamallet
Dexametasona
Dexametasona [INN-Spanish]
Dexametasone
Dexameth
Dexamethansone
DEXAMETHASONE
Dexaméthasone
Dexamethasone acetate
Dexamethasone alcohol
Dexamethasone base
Dexamethasone intensol
DEXAMETHASONE METASULFOBENZOATE SODIUM
DEXAMETHASONE PALMITATE
Dexamethasone sodium phosphate
|
DEXAMETHASONE VALERATE
Dexamethasone-omega
Dexamethasonum
Dexamethasonum [INN-Latin]
Dexamethazone
Dexamonozon
Dexapolcort
Dexapos
Dexaprol
Dexa-scheroson
Dexa-sine
Dexason
Dexasone
Dexasone 0.5MG
Dexasone 0.75MG
Dexasone 4MG
Dexasporin
Dex-ide
Dexinolon
Dexinoral
Dexone
DEXONE 0.5
DEXONE 0.75
DEXONE 1.5
DEXONE 4
Dexonium
Dexpak
DEXSOL
Dextelan
DEXTENZA
DEXYCU KIT
Dezone
Dinormon
DROPODEX
DXM
DXM833
DXMS
ECR brand OF dexamethasone
Fluormethylprednisolone
Fluormone
Fluorocort
Fortecortin
Foy brand OF dexamethasone
Gammacorten
GPPE EAR SPY
Hexadecadrol
Hexadrol
Hexadrol elixir
Hexadrol Tablets
HL-Dex
ICN brand OF dexamethasone
IontoDex
Isopto-dex
ISV-305
KORTICO INJECTION
Lokalison F
Loverine
Luxazone
MARTAPAN
Maxidex
Maxidex ont 0.1%
Maxidex sus 0.1%
Maxitrol
Mediamethasone
Merck brand OF dexamethasone
Merz brand 1 OF dexamethasone
Merz brand 2 OF dexamethasone
Methylfluorprednisolone
Mexidex
Millicorten
Mymethasone
Naquasone (veterinary)
NEODECADRON
Neomycin and polymyxin b sulfates and dexamethasone
Neomycin and polymyxin b sulphates and dexamethasone
NSC 34521
NSC-34521
Ocu-trol
Oradexon
OTO-104
OTOMIZE
OZURDEX
Pet derm III
Pet-Derm Iii
PHL-Dexamethasone
PMS Dexamethasone elixir 0.5mg/5ML
PMS-Dexamethasone
Policort
Posurdex
Prednisolon F
Prednisolone F
Prodex
Sandoz dexamethasone
SK-Dexamethasone
SOFRADEX
SPERSADEX COMP
Spoloven
Sunia sol D
Superprednol
Tobradex
Tobramycin and dexamethasone
Tresaderm (veterinary)
Turbinaire
Visumetazone
|
|
13 |
|
Racepinephrine |
Approved, Vet_approved |
Phase 4 |
|
51-43-4, 329-65-7 |
838 5816 |
Synonyms:
(−)-(R)-epinephrine
(-)-(R)-Epinephrine
(-)-3,4-Dihydroxy-a-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-a-[(methylamino)methyl]-benzyl alcohol
(-)-3,4-Dihydroxy-a-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-alpha-[(methylamino)methyl]-benzyl alcohol
(-)-3,4-DIHYDROXY-ALPHA-[(METHYLAMINO)METHYL]BENZYL ALCOHOL(-)-3,4-DIHYDROXY-ALPHA-[(METHYLAMINO)METHYL]-BENZYL ALCOHOL
(-)-3,4-Dihydroxy-alpha-[2-(methylamino)ethyl]benzyl alcohol
(−)-3,4-dihydroxy-α-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-α-((methylamino)methyl)benzyl alcohol
(-)-Adrenaline
(−)-ADRENALINE
(-)-Epinephrine
(+-)-Adrenaline
(+-)-Epinephrine
(R)-(-)-Adnephrine
(R)-(-)-Adrenaline
(R)-(−)-ADRENALINE
(R)-(-)-Epinephrine
(R)-(-)-Epirenamine
(R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
(R)-Adrenaline
(R)-Epinephrine
2-(Methylamino)-1-(3,4-dihydroxyphenyl)ethanol
4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
4-[(1R)-1-HYDROXY-2-METHYLAMINOETHYL]BENZENE-1,2-DIOL
4-[(1R)-1-HYDROXY-2-METHYLAMINO-ETHYL]BENZENE-1,2-DIOL
4-[(1R)-1-HYDROXY-2-METHYLAMINO-ETHYL]PYROCATECHOL
Acetate, epinephrine
Adnephrine
ADREN CO
ADRENACLICK
Adrenal
Adrenalin
adrenalin|Auvi-Q®|Epipen®|l-adrenaline|L-epinephrine|levoepinephrine
Adrenaline
Adrénaline
Adrenaline acid tartrate
Adrenaline bitartrate
Adrenaline hydrochloride
Adrenaline hydrochloride, racemic mixture
Adrenaline, racemic
Adrenaline, racemic mixture
adrenaline|epinephrine
Adrenine
Adrin
Allergan brand OF adrenaline hydrochloride
ANA-GUARD
Ana-kit
ANAPEN
ANAPHYLACTIC SHOCK DRUG KIT
ASMA-VYDRIN
ASTHMAHALER
Auvi-Q
Bird brand OF racepinefrine hydrochloride
Bosmin
Bronkaid mist
BROVON
Chelafrin
DL-Adrenaline
EMERADE
EPI E Z PEN JR
Epifrin
Epiglaufrin
Epinefrin
Epinefrina
Epinephran
Epinephrin
EPINEPHRINE
Epinephrine acetate
Epinephrine bitartrate
EPINEPHRINE HCL
Epinephrine hydrochloride
Epinephrine hydrochloride, racemic mixture
Epinephrine hydrogen tartrate
Epinephrine racemic
Epinephrine, racemic
Epinephrine, racemic mixture
Epinephrinum
Epipen
|
EPIPEN E Z PEN
Epipen JR
EPIPEN JR.
Epirenan
Epitrate
Eppy
Exadrin
Glauposine
GPPE INH SOLN
Hemisine
Hemostasin
Hemostatin
Hydrochloride, racepinephrine
Hypernephrin
Isoptoepinal
JEXT
L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
L-Adrenaline
L-DETHYLAMINOETHANOLCATECHOL
L-Epinephrine
L-Epirenamine
Levoepinephrine
LEVO-METHYLAMINOETHANOLCATECHOL
Levorenen
Levorenin
Levorenine
Levoreninum
L-Methylaminoethanolcatechol
Lyodrin
Lyophrin
Medihaler-epi
Methylarterenol
Micronefrin
Micronephrine
Mixture adrenaline, racemic
Mixture epinephrine, racemic
Mucidrina
Nephridine
Nieraline
NSC-62786
Paranephrin
Primatene
Primatene mist
R-(-)-Epinephrine
Racemic adrenaline
Racemic epinephrine
Racemic mixture adrenaline
Racemic mixture epinephrine
Racepinefrina
Racepinefrine
Racepinefrinum
Racepinephrine
Racepinephrine hydrochloride
Renaglandin
Renaleptine
Renalina
Renoform
Renostypticin
Renostyptin
RIDDOBRON
RIDDOFAN
RYBARVIN
Scurenaline
Simplene
SOLN MADE TO RYBARVIN FOR
Styptirenal
Supracapsulin
Supranephrane
Suprarenaline
Suprarenin
Surrenine
Sus-phrine
SUS-PHRINE SULFITE FREE
SUS-PHRINE SULFITE-FREE
SYMJEPI
Takamina
TWINJECT
TWINJECT 0.15
TWINJECT 0.3
Vaponefrin
Vasoconstrictine
Vasotonin
|
|
14 |
|
Bupivacaine |
Approved, Investigational |
Phase 4 |
|
2180-92-9, 38396-39-3 |
2474 |
Synonyms:
(+-)-Bupivacaine
(±)-bupivacaine
(RS)-bupivacaine
1-Butyl-2',6'-pipecoloxylidide
1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
Abbott brand OF bupivacaine hydrochloride
ANEKAIN
Anhydrous, bupivacaine
Astra brand OF bupivacaine hydrochloride
AstraZeneca brand OF bupivacaine hydrochloride
Aventis brand OF bupivacaine hydrochloride
Bloqueina
Braun brand OF bupivacaine hydrochloride
Braun, bupivacaina
Bucaine
Bupivacain janapharm
Bupivacain RPR
Bupivacaina
Bupivacaina [INN-Spanish]
Bupivacaina braun
BUPIVACAINE
Bupivacaine anhydrous
Bupivacaine carbonate
Bupivacaine HCL
Bupivacaine HCL kit
Bupivacaine hydrochloride
Bupivacaine monohydrochloride, monohydrate
Bupivacain-RPR
Bupivacainum
Bupivacainum [INN-Latin]
Bupivan
Buvacaina
|
Carbonate, bupivacaine
Carbostesin
CBupivacaine
Chirocaine
DepoBupivacaine
dl-1-Butyl-2',6'-pipecoloxylidide
DL-Bupivacaine
DL-Bupivacaine|Exparel®|Marcain®|Posimir®|Sensorcaine®|W-7|Xaracoll®
Dolanaest
DUR-843
Exparel
Hydrochloride, bupivacaine
Inibsa brand OF bupivacaine hydrochloride
Janapharm, bupivacain
Jenapharm brand OF bupivacaine hydrochloride
LAC-43
LIQ865
LIQ-865
Marcain
Marcaina
Marcaine
Marcaine HCL
Marcaine Spinal
Pisa brand OF bupivacaine hydrochloride
Racemic bupivacaine
Sensorcaine
Sensorcaine-MPF
Sensorcaine-MPF Spinal
SKY-0402
Strathmann brand OF bupivacaine hydrochloride
Svedocain sin vasoconstr
Transdur-Bupivacaine
|
|
15 |
|
Iron isomaltoside 1000 |
Approved, Investigational |
Phase 4 |
|
1370654-58-2 |
|
Synonyms:
|
16 |
|
Bupropion |
Approved |
Phase 4 |
|
31677-93-7, 34841-39-9, 34911-55-2 |
444 |
Synonyms:
(+-)-1-(3-Chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone
(+-)-Bupropion
Amfebutamona
Amfebutamone
AMFEBUTAMONE HCL
amfebutamone|BW-323|Wellbutrin®|Zyban®
Amfebutamonum
BUPROPION
BUPROPION HCL
Bupropion hydrochloride
Bupropion hydrochloride, (+-)-isomer
Bupropion, (+-)-isomer
BW-323
Esteve brand OF bupropion hydrochloride
FORFIVO XL
glaxo Wellcome brand 1 OF bupropion hydrochloride
|
glaxo Wellcome brand 2 OF bupropion hydrochloride
glaxo Wellcome brand 3 OF bupropion hydrochloride
GlaxoSmithKline brand 1 OF bupropion hydrochloride
GlaxoSmithKline brand 2 OF bupropion hydrochloride
NSC-315851
Quomen
Wellbatrin
Wellbutrin
WELLBUTRIN 100
WELLBUTRIN 75
WELLBUTRIN SR
WELLBUTRIN XL
Zyban
Zyban (anti-smoking)
Zyban (bupropion)
Zyntabac
|
|
17 |
|
Dopamine |
Approved |
Phase 4 |
|
62-31-7, 51-61-6 |
681 |
Synonyms:
2-(3,4-Dihydroxyphenyl)ethylamine
3,4 Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenylethylamine
3-Hydroxytyramine
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)-pyrocatechol
4-(2-AZANYLETHYL)BENZENE-1,2-DIOL
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
ASL-279
CARBILEV
Deoxyepinephrine
Dopamin
Dopamina
DOPAMINE
DOPAMINE HCL
|
Dopamine hydrochloride
DOPAMIN-NATTERMAN
Dopaminum
Dopastat
Dophamine
DOPMIN
Dynatra
Hydrochloride, dopamine
Hydroxytyramin
Hydroxytyramine
Intropin
Medopa
NSC-169105
NSC-173182
Oxytyramine
PARCOPA
Revivan
SABAX DOPAMIN
SELECTAJET
SINEMET
|
|
18 |
|
Zinc oxide |
Approved |
Phase 4 |
|
1314-13-2 |
|
Synonyms:
óxido de cinc
oxyde de zinc
Zinc (as oxide)
Zinc (as zinc oxide)
Zinc oxide
|
Zinc óxido
Zinc white
Zinci oxydum
Zincum oxydatum
Zinkoxid
|
|
19 |
|
Celecoxib |
Approved, Investigational |
Phase 4 |
|
169590-42-5 |
2662 |
Synonyms:
4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENE-1-SULFONAMIDE
4-[5-(4-METHYLPHENYL)-3-TRIFLUOROMETHYL)-1H-PYRAZOL-YL]BENZENESULFONAMIDE
CELEBRA
Celebrex
CELECOX
Celecox®|Elyxyb® (DFN-15; oral solution)|Onsenal®|SC-58635|SC58635
Celecoxib
Célécoxib
|
Celecoxibum
Celocoxib
DFN15
DFN-15
Onsenal
p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide
p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulphonamide
SC-58635
|
|
20 |
|
Ibuprofen |
Approved |
Phase 4 |
|
15687-27-1 |
3672 |
Synonyms:
(+-)-2-(p-Isobutylphenyl)propionate
(+-)-2-(p-Isobutylphenyl)propionic acid
(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetate
(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid
(+-)-a-Methyl-4-(2-methylpropyl)benzeneacetate
(+-)-a-Methyl-4-(2-methylpropyl)benzeneacetic acid
(+-)-Ibuprofen
(+-)-p-Isobutylhydratropate
(+-)-p-Isobutylhydratropic acid
(+-)-Α-methyl-4-(2-methylpropyl)benzeneacetate
(+-)-Α-methyl-4-(2-methylpropyl)benzeneacetic acid
(±)-2-(P-ISOBUTYLPHENYL)PROPIONIC ACID
(±)-IBUPROFEN
(±)-P-ISOBUTYLHYDRATROPIC ACID
(±)-Α-METHYL-4-(2-METHYLPROPYL)BENZENEACETIC ACID
(4-Isobutylphenyl)-alpha-methylacetate
(4-Isobutylphenyl)-alpha-methylacetic acid
(4-Isobutylphenyl)-a-methylacetate
(4-Isobutylphenyl)-a-methylacetic acid
(4-Isobutylphenyl)-α-methylacetate
(4-Isobutylphenyl)-α-methylacetic acid
(RS)-Ibuprofen
2-(4-Isobutylphenyl)propanoate
2-(4-Isobutylphenyl)propanoic acid
4-Isobutylhydratropate
4-Isobutylhydratropic acid
a-(4-Isobutylphenyl)propionate
a-(4-Isobutylphenyl)propionic acid
a-(p-Isobutylphenyl)propionate
a-(p-Isobutylphenyl)propionic acid
ACHES-N-PAIN
Actiprofen
Adran
Advil
ADVIL LIQUI-GELS
ADVIL MIGRAINE LIQUI-GELS
Advil®|Brufen®|ibuprofen lysine|ibuprofen sodium|Motrin®|Nurofen®|U-18573
alpha-(4-Isobutylphenyl)propionate
alpha-(4-Isobutylphenyl)propionic acid
alpha-(p-Isobutylphenyl)propionate
alpha-(p-Isobutylphenyl)propionic acid
alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid
alpha-p-Isobutylphenylpropionate
alpha-p-Isobutylphenylpropionic acid
Aluminum salt ibuprofen
Amersol
Amibufen
ANADIN JOINT PAIN
ANADIN LIQUIFAST
ANADIN PERIOD PAIN RELIEF
ANADIN ULTRA
Anco
Andran
Anflagen
Apo-Ibuprofen
Apsifen
APSIFEN-F
ARTHROFEN 200
ARTHROFEN 400
ARTHROFEN 600
Artril 300
Bluton
Brufanic
Brufen
BRUFEN RET
Brufort
Buburone
Butylenin
Calcium salt ibuprofen
CALDOLOR
CAP-PROFEN
CHILDREN'S ADVIL
CHILDREN'S ADVIL-FLAVORED
CHILDREN'S ELIXSURE
CHILDREN'S IBUPROFEN
CHILDREN'S MOTRIN
CODAFEN CONTINUS
Codral
CO-OP
CUPROFEN FOR CHILD
CUPROFEN PLUS
DEEP RELIEF
Dolgin
Dolgirid
Dolgit
Dolocyl
Dolo-dolgit
Duralbuprofen
Ebufac
Emodin
Epobron
Femadon
FEMAFEN
FENBID
FENBID FTE
Fenbid Spansule
FENPAED
FEVERFEN
FLEXIMEX
Haltran
I.V. solution, ibuprofen
IB-100
Ibu
Ibu-attritin
IBUCALM
IBUDERM
IBUFAC
Ibufen
IBUGEL
IBUGEL FTE
IBULAR
IBULEVE
IBUMED
Ibumetin
IBUMOUSSE
IBUPRIN
Ibuprocin
IBUPROFEN
Ibuprofen i.v. solution
Ibuprofen zinc
|
Ibuprofen, (+-)-isomer
Ibuprofen, (R)-isomer
Ibuprofen, (S)-isomer
Ibuprofen, aluminum salt
Ibuprofen, calcium salt
Ibuprofen, copper (2+) salt
Ibuprofen, magnesium salt
Ibuprofen, potassium salt
Ibuprofen, sodium salt
Ibuprofen, zinc salt
Ibuprofene
Ibuprofeno
Ibuprofenum
Ibuprofen-zinc
IBUPROHM
IBUPROPHEN
IBU-SLO
IBUSPRAY
IBU-TAB
IBU-TAB 200
Ibutid
IBUTIME
Ifen
Inabrin
Inoven
IP 82
IP-82
ISISFEN
JUNIFEN
JUNIOR STRENGTH ADVIL
JUNIOR STRENGTH IBUPROFEN
JUNIOR STRENGTH MOTRIN
Lamidon
Lebrufen
LIDIFEN
LIDIFEN-F
Liptan
LOBUFEN
M01AE01
Magnesium salt ibuprofen
MANDAFEN
MANORFEN
MAXA-GESIC
Medipren
MIDOL
Midol 200
MIDOL LIQUID GELS
MIGRAFEN
Motrin
MOTRIN IB
MOTRIN MIGRAINE PAIN
Mynosedin
Napacetin
NeoProfen
Nobfelon
Nobfen
Nobgen
NOVAPRIN
Novogent N
Novoprofen
NSC-256857
Nuprin
Nurofen
NUROFEN 400
NUROFEN BACK PAIN SR
NUROFEN CHILD
NUROFEN FOR CHILD
NUROFEN PLUS
NUROFEN RECOVERY
NUROFEN SINUS
NUROFEN SOLB
ORBIFEN
PACIFENE
Pantrop
Para-Isobutylhydratropic Acid
PAXOFEN
PEDEA
Pediaprofen
Pedia-Profen
PEDIATRIC ADVIL
PHENSIC
PHOR PAIN
PHORPAIN
PHORPAIN MAX STRGH
p-Isobutyl-2-phenylpropionate
p-Isobutyl-2-phenylpropionic acid
p-Isobutylhydratropate
p-Isobutylhydratropic acid
Potassium salt ibuprofen
PROFEN
PROFLEX
PROFLEX SR
Rafen
RD 13621
Rebugen
RELCOFEN
RIMAFEN
Roidenin
Rufen
Salprofen
Salt ibuprofen, magnesium
Salt ibuprofen, sodium
Salt ibuprofen, zinc
Seclodin
Sodium salt ibuprofen
Suspren
Tabalon
TAB-PROFEN
Trauma dolgit gel
Trauma-dolgit gel
TraumaDolgit gel
Trendar
U-18573
Urem
Zinc salt ibuprofen
Α-(4-isobutylphenyl)propionate
Α-(4-isobutylphenyl)propionic acid
Α-(p-isobutylphenyl)propionate
Α-(p-isobutylphenyl)propionic acid
|
|
21 |
|
Esomeprazole |
Approved, Investigational, Vet_approved |
Phase 4 |
|
73590-58-6, 119141-88-7 |
9568614 4594 |
Synonyms:
( -)-Omeprazole
(−)-omeprazole
(-)-Omeprazole
(S)-(−)-omeprazole
(S)-(-)-Omeprazole
(S)-5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole
(S)-5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-1H-benzimidazole
(S)-Omeprazole
(S)-omeprazole|Nexium®
2,3,5-Trimethylpyridine/Omeprazole
A02BC05
Alenia
Antra
Antra mups
AstraZeneca brand OF esomeprazole magnesium
Audazol
Aulcer
Axagon
Belmazol
Ceprandal
Danlox
Demeprazol
Desec
Dizprazol
Dudencer
Elgam
Emeproton
EMOZUL
Epirazole
Erbolin
Escz
Esofag
Esomeprazol
Esomeprazole
Ésoméprazole
Esomeprazole magnesium
Esomeprazole potassium
Esomeprazole sodium
Esomeprazole strontium
Esomeprazole strontium anhydrous
Esomeprazolum
Esomperazole
Esopral
Exter
Gasec
Gastrimut
Gastroloc
Gibancer
H 168/68
H 168/68|Losec®|Prilosec®
H-168/68
Indurgan
Inexium paranova
Inhibitron
Inhipump
Lensor
Logastric
Lomac
Losec
LOSEC MUPS
Lucen
Magnesium, omeprazole
Mepral
MEZZOPRAM
Miol
Miracid
Mopral
Morecon
Nexiam
Nexium
NEXIUM CONTROL
NEXIUM I.V.
Nexium IV
Nilsec
Nopramin
|
Nuclosina
Ocid
Olexin
Omapren
Omebeta 20
Omed
Omegast
OMEP
Omepradex
Omepral
Omeprazol
Omeprazol [INN-Spanish]
Omeprazole
Omeprazole magnesium
Omeprazole pellets
Omeprazole S-form
Omeprazole sodium
Omeprazolum
Omeprazolum [INN-Latin]
Omeprazon
Omeprol
OMERAN
Omesek
Omez
Omezol
Omezolan
Omid
Omisec
Omizac
OMP
Ompanyt
OMZ
Ortanol
Osiren
Ozoken
Paprazol
Parizac
Pepticum
Pepticus
Peptilcer
Perprazole
Prazentol
Prazidec
Prazolit
Prestwick_808
Prilosec
Prilosec otc
Procelac
Proclor
Prysma
Ramezol
Regulacid
Result
Sanamidol
Secrepina
Sodium, omeprazole
Strontium, esomeprazole
Tedec ulceral
Ulceral
Ulcesep
Ulcometion
Ulcozol
Ulcsep
Ulsen
Ultop
Ulzol
VENTRA
Victrix
ZANPROL
Zefxon
Zegerid
Zepral
Zimor
Zoltum
|
|
22 |
|
Adalimumab |
Approved, Experimental |
Phase 4 |
|
331731-18-1 |
|
Synonyms:
ADALIMUMAB
ADALIMUMAB (GENETICAL RECOMBINATION)
ADALIMUMAB BETA
adalimumab-adaz
adalimumab-adbm
adalimumab-afzb
adalimumab-atto
adalimumab-bwwd
adalimumab-fkjp
AVT-02
BI695501
CT-P17
D2E7
FKB327
|
FKB-327
GP2017
HLX03
HLX-03
HUMIRA
Humira Pen
IG GAMMA-1 CHAIN C REGION
LU200134
LU-200134
M923
MSB11022
MSB-11022
ZRC3197
ZRC-3197
|
|
23 |
|
Mesalazine |
Approved |
Phase 4 |
|
89-57-6 |
4075 |
Synonyms:
3-Carboxy-4-hydroxyaniline
5 Aminosalicylate
5 Aminosalicylic acid
5-Aminosalicylate
5-Aminosalicylic acid
5-aminosalicylic acid|5-ASA|mesalamine (USAN)|Pentasa®
5-ASA
Allphar brand OF mesalamine
Antigen brand OF mesalamine
Apriso
Asacol
ASACOL HD
Asacolitin
Asacolon
Ascolitin
Axcan brand OF mesalamine
Byk brand OF mesalamine
Canasa
Celltech brand OF mesalamine
Claversal
COLTEC EC
Delzicol
Falk brand OF mesalamine
Farmasa brand OF mesalamine
Ferring brand OF mesalamine
Fisalamine
Fivasa
GlaxoSmithKline brand OF mesalamine
Henning berlin brand OF mesalamine
Hydrochloride, mesalamine
Iialda
IPOCOL
Lialda
Lixacol
m Aminosalicylic acid
m-Aminosalicylate
m-Aminosalicylic acid
|
MAX-002
Merckle brand OF mesalamine
Mesalamine
Mesalamine hydrochloride
Mesalamine monosodium salt
Mesalazina
Mesalazine
Mésalazine
Mesalazinum
Mesasal
MESREN MR
Meta aminosalicylic acid
Meta-aminosalicylic acid
MEZAVANT XL
Monosodium salt, mesalamine
Norgine brand OF mesalamine
Novo 5 asa
Novo5 asa
Novo-5 asa
Novopharm brand OF mesalamine
NSC-38877
OCTASA
p-Aminosalicylsaeure
Pentasa
PENTASA SR
Procter and gamble brand OF mesalamine
Provalis brand OF mesalamine
Rowasa
Salofalk
Sanofi synthelabo brand OF mesalamine
Schering plough brand OF mesalamine
Schering-plough brand OF mesalamine
Sfrowasa
SmithKline brand OF mesalamine
Solvay brand OF mesalamine
Yamanouchi brand OF mesalamine
|
|
24 |
|
Certolizumab pegol |
Approved |
Phase 4 |
|
428863-50-7 |
|
Synonyms:
|
CERTOLIZUMAB PEGOL
CIMZIA
PHA-738144
|
|
25 |
|
Golimumab |
Approved |
Phase 4 |
|
476181-74-5 |
|
Synonyms:
|
26 |
|
Bisacodyl |
Approved |
Phase 4 |
|
603-50-9 |
2391 |
Synonyms:
4-{[4-(acetyloxy)phenyl](pyridin-2-yl)methyl}phenyl acetic acid
Agaroletten
apo Bisacodyl
apo-Bisacodyl
Aventis brand OF bisacodyl
Bekunis bisacodyl
Bicol
BIOLAX
Bisac evac
Bisac-evac
BISACODILO
BISACODYL
Bisacodyl tannex
Bisacodyl uniserts
Bisacodyl, bekunis
Bisacodyl, fleet
BISACODYLE
BISACODYLUM
Bisalax
bisco Lax
bisco Zitron
bisco-Lax
bisco-Zitron
CORRECTOL TABLETS, CAPLETS
dulco Lax
dulco Lax perles
DULCODOS
|
dulco-Lax
Dulcolax
dulco-Lax perles
Dulcolax perles
Durolax
ENTROLAX
FEEN-A-MINT TABLETS
Fleet bisacodyl
Florisan N
Laxagetten
Laxanin
Laxans ratiopharm
Laxans-ratiopharm
Laxbene
Laxysat bürger
Lünolax
PHENOL, 4,4'-(2-PYRIDINYLMETHYLENE)BIS-, DIACETATE (ESTER)
ratio Bisacodyl
ratio-Bisacodyl
Rytmil
SK-BISACODYL
SPIROLAX
Tannex, bisacodyl
THERALAX
Ulcolax
Uniserts, bisacodyl
|
|
27 |
|
Ondansetron |
Approved, Withdrawn |
Phase 4 |
|
99614-02-5 |
4595 |
Synonyms:
A04AA01
Apo-ondansetron
DESMETHYLONDANSETRON
Dihydrate, ondansetron monohydrochloride
EUR-1025
GR-38032
GR-38032F
GR-38032F/GR-38032|ondansetron hydrochloride|ondansetron hydrochloride dihydrate|Zofran®
Hydrochloride, ondansetron
Monohydrochloride dihydrate, ondansetron
Monohydrochloride, ondansetron
Novo-ondansetron
ONDANSETRON
Ondansetron hydrochloride
|
Ondansetron monohydrochloride
Ondansetron monohydrochloride dihydrate
Ondansetron, (+,-)-isomer
Ondansetron, (R)-isomer
Ondansetron, (S)-isomer
PHL-ondansetron
PMS-ondansetron
Ratio-ondansetron
Sandoz ondansetron
Zofran
Zofran odt
Zophren
Zudan
ZUPLENZ
|
|
28 |
|
Infliximab |
Approved |
Phase 4 |
|
170277-31-3 |
|
Synonyms:
ABP 710
BOW015
CA2
CA2 ????
IG GAMMA-1 CHAIN C REGION
INFLECTRA
INFLIXIMAB
Infliximab (genetical recombination)
|
Infliximab-abda
Infliximab-axxq
Infliximab-dyyb
Infliximab-qbtx
NI-071
REMICADE
REMSIMA
TA-650
|
|
29 |
|
Iron |
Approved |
Phase 4 |
|
7439-89-6 |
29936 |
Synonyms:
Carbonyl iron
Eisen
Electrolytic iron
Fe
FE (III) ion
Fe(3+)
Fe(III)
fer
Ferric ion
Ferric iron
Ferrum
|
Ferrum metallicum
Hierro
Iron powder
Iron(3+)
Iron, carbonyl
Iron, electrolytic
Iron, elemental
Iron, ion (fe(3+))
Iron, reduced
Reduced iron
|
|
30 |
|
Ferric maltol |
Approved |
Phase 4 |
|
33725-54-1 |
|
Synonyms:
Accrufer
Ferric maltol
Iron (III) maltol
|
Iron(3+) ion tris(2-methyl-4-oxo-4H-pyran-3-olic acid)
Iron(3+) tris(2-methyl-4-oxo-4H-pyran-3-olate)
|
|
31 |
|
Ferrous fumarate |
Approved |
Phase 4 |
|
141-01-5 |
|
Synonyms:
|
32 |
|
Ascorbic acid |
Approved, Nutraceutical |
Phase 4 |
|
50-81-7 |
54676860 54670067 5785 |
Synonyms:
(+)-Ascorbate
(+)-Ascorbic acid
(+)-Sodium L-ascorbate
[<sup>14</sup>C]-ascorbic acid
3-keto-L-Gulofuranolactone
3-oxo-L-Gulofuranolactone
AA
Acid, ascorbic
Acid, L-ascorbic
Acide ascorbique
Acido ascorbico
ácido ascórbico
Acidum ascorbicum
Acidum ascorbinicum
Adenex
Allercorb
Antiscorbic vitamin
Antiscorbutic vitamin
arco-Cee
Ascoltin
ASCOR
Ascorb
Ascor-b.i.d.
Ascorbajen
Ascorbate
Ascorbate radical
Ascorbate, ferrous
Ascorbate, magnesium
Ascorbate, sodium
ASCORBIC ACID
Ascorbic acid radical
Ascorbic acid, monosodium salt
Ascorbicab
Ascorbicap
Ascorbicin
Ascorbin
Ascorbinsaeure
Ascorbinsäure
Ascorbutina
Ascorin
Ascorteal
Ascorvit
Cantan
Cantaxin
Catavin C
Ce lent
Cebicure
Cebid
Cebion
Cebione
Cecon
Cee-caps TD
Cee-vite
Cegiolan
Ceglion
Ceklin
Celaskon
Celin
Cell C
Cemagyl
Ce-mi-lin
Cemill
Cenetone
Cenolate
Cereon
Cergona
Cescorbat
Cetamid
Cetane
Cetane-caps TC
Cetane-caps TD
Cetebe
Cetemican
Cevalin
Cevatine
Cevex
Cevi-bid
Cevimin
Ce-vi-sol
Cevital
Cevitamate
Cevitamic acid
Cevitamin
Cevitan
Cevitex
Cewin
Chewcee
|
Ciamin
Cipca
Citriscorb
Citrovit
C-Level
C-Long
Colascor
Concemin
C-Quin
C-Span
C-Vimin
Davitamon C
Di-L-ascorbate, magnesium
Dora-C-500
Duoscorb
e 300
e300
e-300
Ferrous ascorbate
gamma-Lactone L-threo-hex-2-enonate
gamma-Lactone L-threo-hex-2-enonic acid
HiCee
Hybrin
ido-C
Juvamine
Kangbingfeng
Kyselina askorbova
L Ascorbic acid
L(+)-Ascorbate
L-(+)-Ascorbate
L(+)-Ascorbic acid
L-(+)-Ascorbic acid
L-3-Ketothreohexuronic acid lactone
Laroscorbine
L-Ascorbate
L-Ascorbic acid
Lemascorb
Liqui-cee
L-Lyxoascorbate
L-Lyxoascorbic acid
L-threo-Ascorbic acid
L-Xyloascorbate
L-Xyloascorbic acid
Magnesium ascorbate
Magnesium ascorbicum
Magnesium di L ascorbate
Magnesium di-L-ascorbate
Magnorbin
Meri-c
Monodehydroascorbate radical
Monodehydroascorbic acid radical
Natrascorb
Natrascorb injectable
Planavit C
Proscorbin
Redoxon
Ribena
Ronotec 100
Rontex 100
Roscorbic
Rovimix C
Scorbacid
Scorbu C
Scorbu-C
Secorbate
Semidehydroascorbate
Semidehydroascorbic acid
Sodascorbate
Sodium ascorbate
Suncoat VC 40
Testascorbic
VASC
Vicelat
Vicin
Vicomin C
Viforcit
Viscorin
Viscorin 100m
Vitace
Vitacee
Vitacimin
Vitacin
Vitamin C
Vitamina C
Vitamisin
Vitascorbol
Xitix
|
|
33 |
|
2,4-thiazolidinedione |
Investigational |
Phase 4 |
|
2295-31-0 |
5437 |
Synonyms:
2,4(3H,5H)-Thiazoledione
2,4-Dioxothiazolidine
2,4-Thiazolidinedione
|
2,4-Thiazolidinedione potassium
THIAZOLIDINE-2,4-DIONE
Thiazolidinedione
|
|
34 |
|
Copper Supplement |
|
Phase 4 |
|
|
|
35 |
|
Serotonin Receptor Agonists |
|
Phase 4 |
|
|
|
36 |
|
Anti-Inflammatory Agents, Non-Steroidal |
|
Phase 4 |
|
|
|
37 |
|
Analgesics, Non-Narcotic |
|
Phase 4 |
|
|
|
38 |
|
Analgesics |
|
Phase 4 |
|
|
|
39 |
|
Anesthetics, Intravenous |
|
Phase 4 |
|
|
|
40 |
|
Anesthetics, General |
|
Phase 4 |
|
|
|
41 |
|
Hypnotics and Sedatives |
|
Phase 4 |
|
|
|
42 |
|
GABA Modulators |
|
Phase 4 |
|
|
|
43 |
|
Heptavalent Pneumococcal Conjugate Vaccine |
|
Phase 4 |
|
|
|
44 |
|
Bronchodilator Agents |
|
Phase 4 |
|
|
|
45 |
|
Anti-Asthmatic Agents |
|
Phase 4 |
|
|
|
46 |
|
Respiratory System Agents |
|
Phase 4 |
|
|
|
47 |
|
Anti-Ulcer Agents |
|
Phase 4 |
|
|
|
48 |
|
Antacids |
|
Phase 4 |
|
|
|
49 |
|
Epinephryl borate |
|
Phase 4 |
|
|
|
50 |
|
Adrenergic beta-Agonists |
|
Phase 4 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 1013)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Randomized Cross-Over Trial of Captafer® vs. Oral Iron Sulfate in the Treatment of Iron Deficiency Anemia in Patients With Inflammatory Bowel Disease |
Unknown status |
NCT02774057 |
Phase 4 |
Captafer®;Iron Sulfate |
2 |
Anemia Treatment in Inflammatory Bowel Disease: Predictive Factors of Response to Oral Iron Treatment |
Unknown status |
NCT02760940 |
Phase 4 |
oral liposomal iron |
3 |
Evaluating the Efficacy of Weekly Folic Acid in Pediatric Inflammatory Bowel Disease Patients on Methotrexate |
Unknown status |
NCT03860012 |
Phase 4 |
Folic Acid |
4 |
Santeon InflixMab biosimILAr Research A Randomized, Controlled, Double Blind, Phase 4 Noninferiority Trial to Assess Efficacy of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission. |
Unknown status |
NCT02452151 |
Phase 4 |
Infliximab-Biosimilar;Infliximab-Innovator |
5 |
The Effect of Probiotics on the Rate of Recovery of Inflammatory Bowel Disease Exacerbation (Crohn's Disease) and Markers of Inflammation |
Unknown status |
NCT01765998 |
Phase 4 |
Probiotic;Placebo |
6 |
Optimal Substitution Dose of the Vitamin D During Winter Time in Patient With Inflammatory Bowel Diseases (IBD) |
Unknown status |
NCT02958501 |
Phase 4 |
Colecalciferol |
7 |
Does Bowel Preparation (Either as a Single or Divided Dose) Produce Better Cleansing and Diagnostic Yield Than no Preparation at All in Small Bowel Capsule Endoscopy |
Unknown status |
NCT03351972 |
Phase 4 |
Klean Prep |
8 |
The Effect of Prucalopride on Small Bowel Transit Time in Patients Undergoing Capsule Endoscopy: A Randomized Controlled Trial |
Unknown status |
NCT02806206 |
Phase 4 |
Prucalopride;Placebo |
9 |
Stricture Definition and Treatment (STRIDENT) Drug Therapy Study |
Unknown status |
NCT03220841 |
Phase 4 |
Adalimumab Injection;Thiopurine |
10 |
Response to Ustekinumab for Anti-tnf Induced Psoriasiform Skin Lesions |
Unknown status |
NCT03629379 |
Phase 4 |
Ustekinumab;Vedolizumab |
11 |
Steroid-induced Mood Changes in Patients With Inflammatory Bowel Disease |
Completed |
NCT01981889 |
Phase 4 |
Prednisone |
12 |
Nurse Administered Propofol Sedation vs. Standard Therapy for Colonoscopy in Patients With IBD. A Randomised Controlled Study on Satisfaction and Adherence to Treatment Program. |
Completed |
NCT01934088 |
Phase 4 |
Propofol;Midazolam;Fentanyl |
13 |
Randomized, Placebo-controlled Trial of Lubiprostone as a Preparation for Capsule Endoscopy |
Completed |
NCT00746395 |
Phase 4 |
Lubiprostone;Placebo |
14 |
Colon Cleasing for Colonoscopy in Patients With IBD Colitis: Efficacy and Acceptability of 4 Liter PEG vs 2 Liter PEG Plus Bisacodil |
Completed |
NCT02248337 |
Phase 4 |
Colon preparation for colonoscopy |
15 |
Open Label Study to Evaluate the Pharmacokinetics of Fidaxomicin in Inflammatory Bowel Disease (IBD) Subjects With Clostridium Difficile Infection (CDI) |
Completed |
NCT02437591 |
Phase 4 |
fidaxomicin |
16 |
A Randomised Controlled Trial Comparing the Efficacy of Intravenous Iron Sucrose and Oral Iron Sulfate in Patients With Iron Deficiency. |
Completed |
NCT01067547 |
Phase 4 |
Iron Sucrose.;Iron sucrose |
17 |
The Influence of 5-Aminosalicylates on Thiopurine Metabolite Levels |
Completed |
NCT00167882 |
Phase 4 |
5-aminosalicylate (Pentasa, Ferring) |
18 |
Comparison of Immune Response to the Human Papillomavirus Vaccine in Young Women With and Without Inflammatory Bowel Disease |
Completed |
NCT01034358 |
Phase 4 |
|
19 |
Gene Regulation by Thiazolidinediones |
Completed |
NCT00567593 |
Phase 4 |
Rosiglitazone |
20 |
Randomized Trial of High Dose vs. Standard Dose Influenza Vaccine in Inflammatory Bowel Disease Patients |
Completed |
NCT02461758 |
Phase 4 |
|
21 |
Precision Dosing Versus Conventional Dosing of Infliximab Maintenance Therapy: a Randomized Controlled Multicenter Study in Patients With IBD in Clinical Remission |
Completed |
NCT02453776 |
Phase 4 |
PRECISION dosing Infliximab |
22 |
Immunogenicity of Hepatitis A Vaccine in Patients With Inflammatory Bowel Disease |
Completed |
NCT01341808 |
Phase 4 |
|
23 |
Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease: A Novel Adjunctive Therapy for Chronic Inflammatory Illness |
Completed |
NCT02162862 |
Phase 4 |
bupropion-SR |
24 |
Multicenter Randomized Open-label Controlled Study to Investigate Treatment Response of IV Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia Secondary to Inflammatory Bowel Disease or Gastric Bypass |
Completed |
NCT02086968 |
Phase 4 |
Injectafer;Ferrous Sulfate tablets |
25 |
Ultra-proactive Therapeutic Drug Monitoring of Infliximab Based on Point-of-care-testing in Inflammatory Bowel Disease: a Pragmatic Trial |
Completed |
NCT04775732 |
Phase 4 |
|
26 |
Treatment of Iron Deficiency Anaemia in Adults and Adolescents With Inflammatory Bowel Disease Using Ferrous Sulphate: Tolerance and Effects on Haemoglobin, Mood, Quality of Life and Fatigue |
Completed |
NCT01991314 |
Phase 4 |
Ferrous sulphate |
27 |
Influence of Immunosuppressive Treatment on Immunological Response to Pneumococcal Conjugated Vaccine (PCV13) in Patients With Inflammatory Bowel Disease |
Completed |
NCT01908283 |
Phase 4 |
|
28 |
Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease: A Prospective, Randomized, Double-Blind, Controlled Trial |
Completed |
NCT01346826 |
Phase 4 |
Standard 2 hours-infusion;Accelerated 1 hour-infusion;Accelerated 30 minutes-infusion |
29 |
A Randomized, Double-blinded, Comparative Trial Comparing the Incidence of Hypophosphatemia in Relation to Repeated Treatment Courses of Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia Due to Inflammatory Bowel Disease |
Completed |
NCT03466983 |
Phase 4 |
Iron Isomaltoside;Ferric Carboxymaltose |
30 |
A Prospective Randomized Trial of Transversus Abdominis Plane (TAP) INtraoperative Block With Bupivacaine/Dexamethasone aGainst Liposomal Bupivacaine (Exparel®): the TINGLE Trial |
Completed |
NCT03723447 |
Phase 4 |
Liposomal bupivacaine;Bupivacaine/epinephrine/dexamethasone |
31 |
Compression Anastomosis: Initial Clinical Experience With the ColonRingTM |
Completed |
NCT01056913 |
Phase 4 |
|
32 |
Evaluation of the Safety and Effectiveness of Switching From Originator (Humira®) to Biosimilar (Imraldi®) Adalimumab in Flanders (SafE-OrBi) |
Completed |
NCT04045782 |
Phase 4 |
single arm |
33 |
Prospective Comparison of VoLumen and Breeza Oral Contrast Agents in Pediatric Patients Undergoing CT and MR Enterography |
Completed |
NCT02946203 |
Phase 4 |
|
34 |
Double-Blind, Placebo-Controlled, Randomized Two-Week Study, Comparing Small Bowel Lesions Associated With Celecoxib (200 mg BID) vs. Ibuprofen (800 mg TID) Plus Omeprazole (20 mg QD) |
Completed |
NCT00640809 |
Phase 4 |
Celecoxib;Ibuprofen plus Omeprazole |
35 |
Efficacy and Safety of Standardized Fecal Microbiota Transplantation for Moderate to Severe Crohn's Diseases |
Recruiting |
NCT01793831 |
Phase 4 |
|
36 |
Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD). |
Recruiting |
NCT04626947 |
Phase 4 |
|
37 |
A Pilot Study Evaluating Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With Vedolizumab |
Recruiting |
NCT03798691 |
Phase 4 |
|
38 |
Identification of Predictive Biomarkers for Response to Biologic Therapies in Inflammatory Bowel Disease by Proteomic and Mass Cytometry Approaches |
Recruiting |
NCT03885713 |
Phase 4 |
|
39 |
Impact of Early Proactive Therapeutic Drug Monitoring on the Durability and Efficacy of Infliximab Therapy in Pediatric Inflammatory Bowel Disease: a Multicenter Open-label Randomized-control Trial |
Recruiting |
NCT05280405 |
Phase 4 |
Infliximab |
40 |
Model-informed Infliximab Dose De-escalation Following Earlier Dose Escalation in Adult Patients With Inflammatory Bowel Diseases |
Recruiting |
NCT04982172 |
Phase 4 |
Infliximab |
41 |
Control Crohn Safe With Episodic Adalimumab Monotherapy as First Line Treatment Study. |
Recruiting |
NCT03917303 |
Phase 4 |
Adalimumab;standard step-up care |
42 |
De-escalation of Anti-TNF Therapy in Adolescents and Young Adults With IBD With Tight Faecal Calprotectin and Trough Level Monitoring |
Recruiting |
NCT04646187 |
Phase 4 |
|
43 |
The Immunogenicity and Safety of Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on Tofacitinib |
Recruiting |
NCT03591770 |
Phase 4 |
|
44 |
The Nordic IBD Treatment Strategy Trial- a Randomised Controlled Trial of Access to a Protein Profile |
Recruiting |
NCT05180175 |
Phase 4 |
Top down treatment if patient at high risk |
45 |
Examining the Effect of Ondansetron on Bowel Prep Success |
Recruiting |
NCT05439772 |
Phase 4 |
Ondansetron |
46 |
Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: Multicentre, Prospective, Randomized Clinical Trial and Economic Evaluation |
Active, not recruiting |
NCT02994836 |
Phase 4 |
Anti-TNF discontinuation: Physiological saline solution |
47 |
Chronotherapy in Inflammatory Bowel Disease |
Active, not recruiting |
NCT04304950 |
Phase 4 |
Evening Group;Morning Group |
48 |
Safety, Efficacy, and Cost-effectiveness of a Reduced Infliximab Infusion Time Protocol |
Active, not recruiting |
NCT05340764 |
Phase 4 |
Infliximab |
49 |
Predicting Response to Iron Supplementation in Patients With Inflammatory Bowel Disease During Induction Therapy |
Not yet recruiting |
NCT05456932 |
Phase 4 |
Intravenous iron;Ferric maltol;Ferrous fumarate |
50 |
A Prospective, Randomized Trial Comparing the Efficacy of Body-weight Based Versus Fixed Corticosteroid Dosage on Remission in Patients With Moderate to Severe Crohn's Disease Flares |
Terminated |
NCT02392286 |
Phase 4 |
Corticosteroid |
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
clidinium
Clidinium bromide
|
Cromolyn
Cromolyn Sodium
|
|